Diginex Ltd Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on August 7, 2026, reports a private offering of securities by Diginex Limited, a foreign private issuer headquartered in London, United Kingdom. The filing details a capital raise executed through Securities Purchase Agreements (SPAs) signed on July 20, 2026, with three unrelated investors.
Key Financial Metrics and Transaction Details
The Company agreed to raise a total of $20 million in exchange for 20 million ordinary shares and 20 million warrants. The filing does not provide current revenue, profit, cash flow, or debt metrics, as this report focuses solely on the capital transaction.
- Total Capital Raised: $20,000,000
- Shares Issued: 20,000,000 ordinary shares
- Warrants Issued: 20,000,000 warrants (exercisable at $1.00 per share for 5 years)
- Introducer Fee: $1,000,000 payable via issuance of 1,000,000 ordinary shares to VB Capital Limited
Material Changes and Payment Schedule
The transaction involves a deferred payment structure where investors receive shares upon initial payment and warrants upon final payment. The filing text contains apparent date inconsistencies for the final payments of Investor 2 and Investor 3, listing dates in 2026 that precede the signing date of July 20, 2026.
| Investor | Total Commitment | Payment Schedule (as stated in filing) |
|---|---|---|
| Investor 1 (Dubai) | $10,000,000 | Initial: $1M by July 30, 2026; Final: $5M by March 31, 2027 |
| Investor 2 (Dubai) | $5,000,000 | Initial: $750k by July 28, 2026; Final: $4.25M by Jan 31, 2026 (Note: Date appears erroneous) |
| Investor 3 (Cayman) | $5,000,000 | Initial: $750k by July 28, 2026; Final: $4.25M by Feb 28, 2026 (Note: Date appears erroneous) |
Guidance, Risks, and Unusual Items
The securities were sold in reliance on exemptions under Section 4(a)(2) of the Securities Act of 1933 and Rule 506 of Regulation D and/or Regulation S. The filing does not provide specific management commentary on future guidance, operational risks, or contingencies beyond the terms of the SPAs. The issuance of 1 million shares as an introducer fee represents a significant dilution event relative to the capital raised.
Investor Verification Checklist
- Payment Date Discrepancies: Verify the correct final payment dates for Investor 2 and Investor 3, as the filing lists dates in early 2026 prior to the July 2026 signing date.
- Dilution Impact: Assess the total dilution from the 20 million new shares plus the 1 million shares issued as the introducer fee.
- Warrant Terms: Confirm the exercise price ($1.00) and 5-year term for the 20 million warrants.
- Investor Identity: Review the attached Exhibits 10.1, 10.2, and 10.3 for full details on the investors and any covenants not summarized in the text.